Superior Immunogenicity Following MF59-Adjuvanted Influenza Vaccination (FLUAD®) in At Risk Adults (18-60 Years Of Age) A Randomized, Observer-Blind Study

Authors
Publication date
1 January 2007
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Padova

    redirect
    oaioai:www.research.unipd.it:1157...
    Last time updated on 12/11/2016